Related Articles
Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line
The prognostic significance of loss of the androgen receptor and neuroendocrine differentiation in prostate biopsy specimens among castration-resistant prostate cancer patients
bcl-2 expression confers androgen independence in androgen sensitive prostatic carcinoma
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer